Literature DB >> 2551105

Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid.

G Partsch1, C Schwarzer, J Neumüller, A Dunky, P Petera, H Bröll, G Ittner, S Jantsch.   

Abstract

Hyaluronic acid (HA) has a dose-related inhibiting effect on the migration and chemotaxis of polymorphonuclear leucocytes (PMN) in vitro. These effects were measured with a new indirect quantitative assay. On average 1 mg HA/ml causes an inhibition to about 80% of the control (spontaneous migration). This effect increased progressively with an increasing HA concentration, and with 4 mg HA/ml only about 19% of the PMN were able to migrate in the in vitro system. Similar results were obtained in the presence of a potent chemotactic factor (leukotriene B4 [LTB4]). In the mean 1 ng LTB4/ml alone stimulated the chemotaxis of PMN by a factor of 3 compared to the spontaneous migration. The highest HA concentration (4 mg/ml) reduced the number of migrating PMN cells to about 17%. From these experiments it may be concluded that the HA in the synovial fluid of the healthy joint has a protective effect against the invasion of PMN cells. This functions is disturbed in inflamed joints by the decrease in the HA concentration and possibly by its depolymerization. The intraarticular application of high molecular weight HA might be an important therapeutic regimen to restore the natural barrier against PMN migration, also in the presence of chemotactic factors and could therefore be helpful for interrupting the inflammatory cascade.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551105

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  10 in total

1.  Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Cell supports of chitosan/hyaluronic acid and chondroitin sulphate systems. Morphology and biological behaviour.

Authors:  Carlos Peniche; Mar Fernández; Gema Rodríguez; Juan Parra; Javier Jimenez; Antonio López Bravo; David Gómez; Julio San Román
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

3.  Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.

Authors:  S Torretta; P Marchisio; V Rinaldi; D Carioli; E Nazzari; L Pignataro
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-01       Impact factor: 2.503

4.  Olfactory dysfunction in acute rhinosinusitis: intranasal sodium hyaluronate as adjuvant treatment.

Authors:  Andrea Ciofalo; Marco de Vincentiis; Giampietro Zambetti; Giancarlo Altissimi; Massimo Fusconi; Antonio Greco; Giancarlo Ottaviano; Giuseppe Magliulo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-27       Impact factor: 2.503

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Hyaluronic acid modulates acute and chronic inflammation.

Authors:  A Ialenti; M Di Rosa
Journal:  Agents Actions       Date:  1994-11

7.  Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections.

Authors:  Austin E F Sheppe; Mariola J Edelmann
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 8.  Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action.

Authors:  Larry W Moreland
Journal:  Arthritis Res Ther       Date:  2003-01-14       Impact factor: 5.156

9.  Hyaluronic Acid-Based Optical Probe for the Diagnosis of Human Osteoarthritic Cartilage.

Authors:  Shuxin Li; Wei Cong; Amirhossein Hakamivala; YiHui Huang; Joseph Borrelli; Liping Tang
Journal:  Nanotheranostics       Date:  2018-07-26

10.  Hyaluronic Acid Loaded with Cerium Oxide Nanoparticles as Antioxidant in Hydrogen Peroxide Induced Chondrocytes Injury: An In Vitro Osteoarthritis Model.

Authors:  Yi-Wen Lin; Chih-Hsiang Fang; Fan-Qi Meng; Cherng-Jyh Ke; Feng-Huei Lin
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.